FDA Inspection
American Red Cross Blood SvcsAmerican Red Cross Blood Svcs – FDA Inspection, Mar 19, 2026
Record Details
This FDA Inspection record concerns American Red Cross Blood Svcs, with an inspection on March 19, 2026, issued by the Atlanta District Office, covering biologics.
View Company Profile
ID · b83ead08-6a62-4abb-a19c-1d806ce32383
Inspection Facts
- Inspection number
- 1308074
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 211.68(b)Written record not kept of program and validation data
Full citation text and observation details available on the Dashboard.
Other FDA inspections of American Red Cross Blood Svcs
6| Date | Classification | Office | Project area |
|---|---|---|---|
| October 16, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 1, 2020 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 22, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 7, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 9, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for American Red Cross Blood Svcs
- FDA Inspection 1220999 - 2023-10-16
- FDA Inspection 1129520 - 2020-09-01
- FDA Inspection 1028108 - 2017-09-22
- FDA Inspection 937686 - 2015-08-07
- FDA Inspection 845761 - 2013-08-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.